139 related articles for article (PubMed ID: 3942847)
1. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression.
Dawes PT; Fowler PD; Clarke S; Fisher J; Lawton A; Shadforth MF
Br J Rheumatol; 1986 Feb; 25(1):44-9. PubMed ID: 3942847
[TBL] [Abstract][Full Text] [Related]
2. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
[TBL] [Abstract][Full Text] [Related]
3. Do drugs change the course of rheumatoid arthritis?
Wright V; Amos R
Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520
[No Abstract] [Full Text] [Related]
4. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
Situnayake RD; McConkey B
J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
[TBL] [Abstract][Full Text] [Related]
6. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis.
McConkey B; Davies P; Crockson RA; Crockson AP; Butler M; Constable TJ; Amos RS
Ann Rheum Dis; 1979 Apr; 38(2):141-4. PubMed ID: 109055
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.
Amos RS; Constable TJ; Crockson RA; Crockson AP; McConkey B
Br Med J; 1977 Jan; 1(6055):195-7. PubMed ID: 832072
[TBL] [Abstract][Full Text] [Related]
8. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
[TBL] [Abstract][Full Text] [Related]
9. Does second-line therapy affect the radiological progression of rheumatoid arthritis?
Pullar T; Hunter JA; Capell HA
Ann Rheum Dis; 1984 Feb; 43(1):18-23. PubMed ID: 6421253
[TBL] [Abstract][Full Text] [Related]
10. Anti-rheumatic drugs and joint damage in rheumatoid arthritis.
Scott DL; Dawes PT; Fowler PD; Grindulis KA; Shadforth M; Bacon PA
Q J Med; 1985 Jan; 54(213):49-59. PubMed ID: 3919415
[TBL] [Abstract][Full Text] [Related]
11. Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study.
Fowler PD; Shadforth MF; Crook PR; Lawton A
Ann Rheum Dis; 1984 Apr; 43(2):200-4. PubMed ID: 6370150
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
Sokka T; Pincus T
J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy.
Tishler M; Caspi D; Yaron M
Clin Rheumatol; 1985 Sep; 4(3):321-4. PubMed ID: 4064588
[TBL] [Abstract][Full Text] [Related]
14. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis.
Walsh L; Davies P; McConkey B
Ann Rheum Dis; 1979 Aug; 38(4):362-3. PubMed ID: 496450
[TBL] [Abstract][Full Text] [Related]
15. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
Dixon JS; Greenwood M; Bird HA
Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
[TBL] [Abstract][Full Text] [Related]
16. Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?
Scott DL; Greenwood A; Davies J; Maddison PJ; Maddison MC; Hall ND
Br J Rheumatol; 1990 Apr; 29(2):126-7. PubMed ID: 2182170
[TBL] [Abstract][Full Text] [Related]
17. Dapsone in rheumatoid arthritis.
McConkey B; Davies P; Crockson RA; Crockson AP; Butler M; Constable TJ
Rheumatol Rehabil; 1976 Aug; 15(3):230-4. PubMed ID: 788118
[TBL] [Abstract][Full Text] [Related]
18. Some aspects of slow-acting drugs in rheumatoid arthritis.
Ansell BM
Agents Actions Suppl; 1979; (5):111-9. PubMed ID: 294130
[No Abstract] [Full Text] [Related]
19. Proceedings: Penicillamine or gold for rheumatoid arthritis? Multicentre trial using 'blind' observers. The first six months.
Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
Ann Rheum Dis; 1974 Jul; 33(4):399. PubMed ID: 4606941
[No Abstract] [Full Text] [Related]
20. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
Warnatz H; Scheiffarth F; Gutmann W
Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
